the compound was found capable of inhibiting the development of disease symptoms or the deterioration of certain immune parameters in three out of five models of spontaneous autoimmune disease : nzb/nzw f1 ( nzb/w ) mice ( lupus glomerulonephritis , sjogren 's disease-like syndrome ) , nzb ( lupus glomerulonephritis , autoimmune haemolytic anaemia ) and os chickens ( thyroiditis ) .
C0004364
autoimmune disease
C1527336
sjogren 's disease